Research institutes CARIM header image

CARIM - Cardiovascular Research Institute Maastricht

CARIM is one of the top institutes for translational cardiovascular research in Europe. It is among the world leaders in the fields of research into vascular and thrombotic disorders and atrial fibrillation, as well as translational heart failure research. It has also made important international contributions to molecular imaging in the cardiovascular field.

Cardiovascular scientists from around the world have joined CARIM because it values open communication, close cooperation, high ambitions, excellent facilities, and a critical learning environment. 

Research

The research within CARIM is divided into three divisions. Each division consists of more interdisciplinary research programmes, each led by a Principal Investigator (PI). The PIs are responsible for the scientific progress of the programme, the mentoring of PhD students and post-docs, and the financials of the programme.
 

Education

CARIM combines high-level scientific research with high-level education of young researchers, and is therefore qualified as a research school by the Royal Netherlands Academy of Arts and Sciences (KNAW) and recognised as an international training site for Early Stage Researchers by the European Union.

CARIM offers a flexible and integrated education and training programme that suits individual ambitions of our students. The education programme consists of a specialization within the FHML master's programmes in Biomedical Sciences and Physician-Clinical Investigator  (MSc/MD) and a contiguous PhD (doctoral) training programme. 

Divisions

The three divisions within CARIM are:

  • Blood
  • Heart
  • Vessels

Macrophages as key to treating liver fibrosis

Sabine Daemen is researching how certain macrophages can slow down fatty liver disease and fibrosis in order to develop new therapies.
Sabine Daemen

More than a student job: five alumni about their unique role in groundbreaking vascular research

  • UM news
What is it like to take part in cutting-edge vascular research as a student, standing in the operating room, directly responsible for handling patient material? Five alumni of the Maastricht MAPEX student team share what they learned, the challenges they faced, and how this experience shaped their...
MAPEX student team

UM to play a more prominent role in Dutch scientific infrastructure

Eleven consortia from various scientific disciplines are set to launch projects of great value to science. The Dutch government is making a total of €197 million available for this purpose. Scientists from Maastricht University (UM) are closely involved in seven of the eleven projects.
Twee onderzoekers bekijken een opstelling.

17 million for Dutch mega cohort: working together to build healthier ageing

MUMC+ is main applicant in the NCC: a unique research infrastructure with data from almost half a million Dutch citizens.
FHML

Three Vidi grants for FHML researchers

Aurélie Carlier, Bart Spronck and Nicole Leibold receive a Vidi grant of up to 850,000 euros to further develop their lines of research.
Aurélie Carlier, Bart Spronck, Nicole Leibold

CARIM works in close cooperation with the Maastricht University Medical Center+ (MUMC+). MUMC+ is known both nationally and internationally for its focus on prevention and taking an integrated approach to health care: from prevention, promotion of good health, and basic care, to top-level clinical diagnostics and treatment. Patient safety is our top priority in all of our endeavours. MUMC+ is part of The Netherlands Federation of University Medical Centres.

Maastricht University Medical Center (MUMC+) logo